Thrivent Financial for Lutherans Has $1.87 Million Position in Addus HomeCare Co. (NASDAQ:ADUS)

Thrivent Financial for Lutherans trimmed its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 4.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 14,056 shares of the company’s stock after selling 612 shares during the quarter. Thrivent Financial for Lutherans owned about 0.08% of Addus HomeCare worth $1,870,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ADUS. Texas Permanent School Fund Corp grew its stake in shares of Addus HomeCare by 0.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after buying an additional 82 shares during the period. Arizona State Retirement System grew its stake in Addus HomeCare by 2.0% in the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after acquiring an additional 87 shares during the period. UMB Bank n.a. increased its holdings in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares in the last quarter. Inspire Investing LLC raised its position in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after purchasing an additional 100 shares during the period. Finally, New York State Teachers Retirement System lifted its holdings in shares of Addus HomeCare by 1.2% in the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after purchasing an additional 100 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Trading Down 2.5 %

Shares of Addus HomeCare stock opened at $121.29 on Friday. The business’s 50-day moving average price is $127.69 and its 200-day moving average price is $123.50. The firm has a market capitalization of $2.20 billion, a PE ratio of 27.76, a price-to-earnings-growth ratio of 2.15 and a beta of 1.04. Addus HomeCare Co. has a 12 month low of $85.43 and a 12 month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 EPS. As a group, analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at $429,165. The trade was a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,500 shares of company stock valued at $1,668,265. 4.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

ADUS has been the subject of a number of recent research reports. KeyCorp began coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. TD Cowen increased their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, Stephens upped their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.